每日三次或每8小时一次。
Three times daily or 8-hourly.
作者信息
Nigam R, Loveday B J, Grainger S L, Maxton D G
出版信息
J R Soc Med. 1986 Jan;79(1):15-6. doi: 10.1177/014107688607900105.
Abstract
The timing of drug ingestion over 24 hours was assessed in 58 outpatients taking drugs three times daily. The mean time between 1st and 2nd dose was 5.7 hours, 2nd and 3rd 6.1 hours and between 3rd and 1st of the next day 12.2 hours. Based on a simulation of hydralazine pharmacokinetics, such irregular administration would increase peak levels by 10% and decrease trough levels by 64% compared with regular 8-hourly doses.
摘要
对58名每日服用三次药物的门诊患者在24小时内的用药时间进行了评估。首剂和第二剂之间的平均时间为5.7小时，第二剂和第三剂之间为6.1小时，第三剂和次日首剂之间为12.2小时。基于对肼屈嗪药代动力学的模拟，与每8小时规律给药相比，这种不规律给药会使峰值水平提高10%，谷值水平降低64%。
相似文献
1
Three times daily or 8-hourly.每日三次或每8小时一次。
J R Soc Med. 1986 Jan;79(1):15-6. doi: 10.1177/014107688607900105.
2
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.噻托溴铵。关于其在慢性阻塞性肺疾病患者中作为维持治疗药物应用的综述。
Treat Respir Med. 2004;3(4):247-68. doi: 10.2165/00151829-200403040-00005.
3
[Rational drug use and clinical pharmacokinetics].
Med Clin (Barc). 2007 Jan 20;128(2):78; author reply 78-9. doi: 10.1016/s0025-7753(07)72493-4.
4
Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.应用峰谷采样设计估算口服清除率的临床重复给药药代动力学试验模拟。
Biol Pharm Bull. 2007 Nov;30(11):2159-62. doi: 10.1248/bpb.30.2159.
5
A calculator program to project serum drug concentration profiles during dosing schedules comprised of two fixed dosing intervals.
Int J Biomed Comput. 1982 Mar;13(2):97-107. doi: 10.1016/0020-7101(82)90028-9.
6
Therapeutic drug monitoring.
Hosp Pharm. 1989 Aug;24(8):614-8, 624-30, 632.
7
8
Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.利用药代动力学-药效学关系预测依从性差的影响。
Clin Pharmacokinet. 2002;41(1):1-6. doi: 10.2165/00003088-200241010-00001.
9
Choosing optimal sampling times for therapeutic drug monitoring.为治疗药物监测选择最佳采样时间。
Clin Pharm. 1985 Jan-Feb;4(1):84-92.
10
Method for controlled establishment of steady-state plasma levels through multiple dosing.
Int J Clin Pharmacol Biopharm. 1978 Mar;16(3):102-4.
引用本文的文献
1
Various administration forms of nitrates and their possibilities.硝酸盐的各种给药形式及其可能性。
Drugs. 1987;33 Suppl 4:23-31. doi: 10.2165/00003495-198700334-00006.
2
Development of long-acting nitrate delivery systems.长效硝酸盐递送系统的研发。
Eur J Clin Pharmacol. 1990;38 Suppl 1:S15-9. doi: 10.1007/BF01417560.
本文引用的文献
1
Treatment of hypertension. Comparative trial of metoprolol Durules (once daily) and metoprolol tablets (twice daily).
Practitioner. 1982 Mar;226(1365):573-5.
2
Slow release beta-adrenoceptor blocking drugs.缓释β-肾上腺素能受体阻滞剂
J R Coll Physicians Lond. 1983 Apr;17(2):126-32.
3
Drug defaulting in a general practice.全科医疗中的药物漏服情况。
Br Med J. 1969 Jan 25;1(5638):218-22. doi: 10.1136/bmj.1.5638.218.
4
Clinical pharmacokinetics of hydrallazine.
Clin Pharmacokinet. 1977 Sep-Oct;2(5):317-29. doi: 10.2165/00003088-197702050-00001.
5
Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.
Eur J Clin Pharmacol. 1979 Mar 26;15(2):97-103. doi: 10.1007/BF00609871.
Zotero 插件